{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:38:36Z","timestamp":1792715916839,"version":"4.5.0"},"reference-count":13,"publisher":"Wiley","license":[{"start":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"DOI":"10.1111\/bjh.70898","type":"journal-article","created":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T23:49:36Z","timestamp":1792712976000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Utilization of zoledronic acid and denosumab in patients with multiple myeloma: Real\u2010world experience from 13\u2009427 patients"],"prefix":"10.1111","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4940-7445","authenticated-orcid":false,"given":"Weiwen","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Endocrinology Medical College of Wisconsin  Milwaukee Wisconsin USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-3547-4511","authenticated-orcid":false,"given":"Farheen","family":"Chunara","sequence":"additional","affiliation":[{"name":"Data Science Institute Medical College of Wisconsin  Milwaukee Wisconsin USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6015-8668","authenticated-orcid":false,"given":"Mackenzie","family":"Lemieux","sequence":"additional","affiliation":[{"name":"Huntsman Cancer Institute University of Utah  Salt Lake City Utah USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3262-8949","authenticated-orcid":false,"given":"Sarvari","family":"Yellapragada","sequence":"additional","affiliation":[{"name":"Department of Lymphoma and Myeloma University of Texas MD Anderson Cancer Center  Houston Texas USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Schinke","sequence":"additional","affiliation":[{"name":"Myeloma Institute University of Arkansas for Medical Sciences  Little Rock Arkansas USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1092-5643","authenticated-orcid":false,"given":"Anita","family":"D'Souza","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Hematology and Oncology Medical College of Wisconsin  Milwaukee Wisconsin USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6464-783X","authenticated-orcid":false,"given":"Ghulam Rehman","family":"Mohyuddin","sequence":"additional","affiliation":[{"name":"Huntsman Cancer Institute University of Utah  Salt Lake City Utah USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8129-0614","authenticated-orcid":false,"given":"Aniko","family":"Szabo","sequence":"additional","affiliation":[{"name":"Data Science Institute Medical College of Wisconsin  Milwaukee Wisconsin USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6913-6526","authenticated-orcid":false,"given":"Meera","family":"Mohan","sequence":"additional","affiliation":[{"name":"Department of Lymphoma and Myeloma University of Texas MD Anderson Cancer Center  Houston Texas USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,10,22]]},"reference":[{"issue":"1","key":"e_1_2_2_2_1","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41408-026-01461-7","article-title":"Toward a cure for multiple myeloma within a decade","volume":"16","author":"Mohty M","year":"2026","journal-title":"Blood Cancer J"},{"issue":"3","key":"e_1_2_2_3_1","doi-asserted-by":"crossref","first-page":"e119","DOI":"10.1016\/S1470-2045(20)30559-3","article-title":"Treatment of multiple myeloma\u2010related bone disease: recommendations from the bone working Group of the International Myeloma Working Group","volume":"22","author":"Terpos E","year":"2021","journal-title":"Lancet Oncol"},{"issue":"9757","key":"e_1_2_2_4_1","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1016\/S0140-6736(10)62051-X","article-title":"First\u2010line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC myeloma IX): a randomised controlled trial","volume":"376","author":"Morgan GJ","year":"2010","journal-title":"Lancet"},{"issue":"3","key":"e_1_2_2_5_1","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S1470-2045(18)30072-X","article-title":"Denosumab versus zoledronic acid in bone disease treatment of newly diagnosed multiple myeloma: an international, double\u2010blind, double\u2010dummy, randomised, controlled, phase 3 study","volume":"19","author":"Raje N","year":"2018","journal-title":"Lancet Oncol"},{"issue":"8","key":"e_1_2_2_6_1","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1002\/ajh.70349","article-title":"The Association of age and Frailty with Adverse Events for bortezomib and carfilzomib: a population\u2010based analysis","volume":"101","author":"Lemieux M","year":"2026","journal-title":"Am J Hematol"},{"key":"e_1_2_2_7_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.archger.2022.104646","article-title":"Development of frailty index using ICD\u201010 codes to predict mortality and rehospitalization of older adults: an update of the multimorbidity frailty index","volume":"100","author":"Lai HY","year":"2022","journal-title":"Arch Gerontol Geriatr"},{"issue":"8","key":"e_1_2_2_8_1","first-page":"2833","article-title":"Patterns of bisphosphonate treatment among patients with multiple myeloma treated at oncology clinics across the USA: observations from real\u2010world data","volume":"26","author":"Kim C","year":"2018","journal-title":"Support Care Cancer"},{"issue":"15","key":"e_1_2_2_9_1","doi-asserted-by":"crossref","first-page":"8520","DOI":"10.1200\/JCO.2020.38.15_suppl.8520","article-title":"A phase II, single\u2010arm study of denosumab in multiple myeloma patients with renal insufficiency","volume":"38","author":"O'Donnell E","year":"2020","journal-title":"J Clin Oncol"},{"issue":"4","key":"e_1_2_2_10_1","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/jgs.15725","article-title":"Effect of bisphosphonates on fracture outcomes among frail older adults","volume":"67","author":"Zullo AR","year":"2019","journal-title":"J Am Geriatr Soc"},{"issue":"5","key":"e_1_2_2_11_1","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.jamda.2019.11.016","article-title":"Association between bisphosphonates and hospitalized Clostridioides difficile infection among frail older adults","volume":"21","author":"McConeghy KW","year":"2020","journal-title":"J Am Med Dir Assoc"},{"issue":"6","key":"e_1_2_2_12_1","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1001\/jamainternmed.2015.0747","article-title":"Efficacy and safety of single\u2010dose zoledronic acid for osteoporosis in frail elderly women: a randomized clinical trial","volume":"175","author":"Greenspan SL","year":"2015","journal-title":"JAMA Intern Med"},{"issue":"2","key":"e_1_2_2_13_1","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1001\/jamaoncol.2019.5426","article-title":"Use of bone\u2010modifying agents among Medicare beneficiaries with multiple myeloma","volume":"6","author":"Gupta A","year":"2020","journal-title":"JAMA Oncol"},{"issue":"21","key":"e_1_2_2_14_1","doi-asserted-by":"crossref","first-page":"5539","DOI":"10.1182\/bloodadvances.2024013600","article-title":"Comparison of patients with myeloma receiving zoledronic acid vs denosumab: a nationwide retrospective cohort study","volume":"8","author":"Mohyuddin GR","year":"2024","journal-title":"Blood Adv"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bjh.70898","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/bjh.70898","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bjh.70898","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T23:49:38Z","timestamp":1792712978000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/bjh.70898"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,22]]},"references-count":13,"alternative-id":["10.1111\/bjh.70898"],"URL":"https:\/\/doi.org\/10.1111\/bjh.70898","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,22]]},"assertion":[{"value":"2026-07-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-22","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-10-22","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"bjh.70898"}}